DPHARMA

1.230

+0.01 (+0.8%)

GENERAL MEETINGS: Outcome of Meeting

DUOPHARMA BIOTECH BERHAD

Type of Meeting	General
Indicator	Outcome of Meeting
Date of Meeting	21 May 2026
Time	09:00 AM

Venue(s)

Conference Hall 1 & 2, Level 3,

Kuala Lumpur Convention Centre,

Kuala Lumpur City Centre,

50088 Kuala Lumpur

Malaysia

Outcome of Meeting

The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company") wishes to announce that the Audited Financial Statements for the financial year ended 31 December 2025 and the Reports of the Directors and Auditors thereon were duly tabled and received at the 25th Annual General Meeting ("AGM") of the Company held today under Agenda 1 as set out in the Notice of the 25th AGM dated 21 April 2026.

The Board also wishes to announce that all the resolutions as set out in the Notice of the 25th AGM dated 21 April 2026 have been passed by the shareholders of Duopharma Biotech at the 25th AGM held today.

The voting in respect of all the resolutions was carried out by way of poll and the results were validated by Scrutineer Solutions Sdn. Bhd., the independent scrutineer appointed by Duopharma Biotech.

Please refer to the attachment for the results of the poll as validated by the independent scrutineer.

This announcement is dated 21 May 2026.

Voting Results

1. Ordinary Resolution 1
Description	To re-elect Datin Paduka Kartini Binti Hj Abdul Manaf who retires in accordance with Article 100 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	155	9
No. of Shares	690,971,634	372,634
% of Voted Shares	99.9461	0.0539
Result	Accepted

2. Ordinary Resolution 2
Description	To re-elect Datuk Wira Arham Bin Abdul Rahman who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	156	8
No. of Shares	691,190,285	153,983
% of Voted Shares	99.9777	0.0223
Result	Accepted

3. Ordinary Resolution 3
Description	To re-elect Dato' Adnan Hisham Bin Pawanteh who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	154	9
No. of Shares	691,190,061	154,107
% of Voted Shares	99.9777	0.0223
Result	Accepted

4. Ordinary Resolution 4
Description	To re-elect Dr. Sharmila A/P Ramachandran who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	156	8
No. of Shares	691,189,657	154,611
% of Voted Shares	99.9776	0.0224
Result	Accepted

5. Ordinary Resolution 5
Description	To re-elect Dr. Hasnita Binti Hashim who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	158	6
No. of Shares	691,287,734	56,534
% of Voted Shares	99.9918	0.0082
Result	Accepted

6. Ordinary Resolution 6
Description	To re-elect Encik Mohamad Idros Bin Mosin who retires in accordance with Article 106 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	152	11
No. of Shares	690,955,085	379,183
% of Voted Shares	99.9452	0.0548
Result	Accepted

7. Ordinary Resolution 7
Description	To approve the payment of Directors fees and Board Committee fees to each of the Non-Executive Directors for the period commencing 22 May 2026 until the conclusion of the next AGM of the Company, and further, to authorise the Directors to pay the said fees among them in such proportions and manner as the Directors may determine.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	157	6
No. of Shares	691,337,431	6,834
% of Voted Shares	99.9990	0.0010
Result	Accepted

8. Ordinary Resolution 8
Description	To approve the payment of benefits to the Non-Executive Directors up to an amount of RM768,000.00 for the period from 22 May 2026 until the conclusion of the next AGM of the Company.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	153	10
No. of Shares	691,259,545	84,720
% of Voted Shares	99.9877	0.0123
Result	Accepted

9. Ordinary Resolution 9
Description	To re-appoint Messrs. KPMG PLT as Auditors of the Company and to authorise the Directors to fix their remuneration.
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	158	7
No. of Shares	691,183,791	163,187
% of Voted Shares	99.9764	0.0236
Result	Accepted

10. Ordinary Resolution 10
Description	To approve the Issuance of New Duopharma Biotech Shares pursuant to the Dividend Reinvestment Plan that provides the Shareholders of the Company with the Option to Elect to Reinvest their Dividend in New Duopharma Biotech Shares ("Dividend Reinvestment Plan").
Shareholder’s Action	For Voting
Voted	For	Against
No. of Shareholders	158	5
No. of Shares	691,336,136	6,666
% of Voted Shares	99.9990	0.0010
Result	Accepted

Please refer attachment below.

Attachments

Duopharma - 25th AGM Poll Result.pdf
320.9 kB

Announcement Info

Company Name	DUOPHARMA BIOTECH BERHAD
Stock Name	DPHARMA
Date Announced	21 May 2026
Category	General Meeting
Reference Number	GMA-18052026-00002
Corporate Action ID	MY260518MEET0002